18F-PSMA 1007 Uptake in a Man With Metastatic Breast Cancer

Clin Nucl Med. 2020 Jun;45(6):e276-e278. doi: 10.1097/RLU.0000000000003013.

Abstract

A 72-year-old man, who is known with a case of metastatic carcinoma of the breast, was referred for F-PMSA 1007 PET/CT with clinical suspicion of synchronous prostate cancer. F-PSMA 1007 PET/CT scan detected no abnormal tracer concentrating lesion in the prostate gland; however, abnormal tracer concentration was noted in soft tissue lesions in left breast, metastatic lymph nodes, and skeletal lesions. Compared with F-FDG PET/CT, more bone lesions were detected on F-PSMA 1007 imaging. The findings of our case open the possibility of imaging metastatic breast cancer with F-PSMA 1007 in men.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Breast Neoplasms, Male / diagnostic imaging
  • Breast Neoplasms, Male / metabolism*
  • Breast Neoplasms, Male / pathology*
  • Fluorine Radioisotopes*
  • Humans
  • Male
  • Neoplasm Metastasis
  • Niacinamide / analogs & derivatives*
  • Niacinamide / metabolism
  • Oligopeptides / metabolism*
  • Positron Emission Tomography Computed Tomography

Substances

  • Fluorine Radioisotopes
  • Oligopeptides
  • PSMA-1007
  • Niacinamide
  • Fluorine-18